A generic image of a line graph
Markets

Leon Cooperman Adds Google and Buys Pfizer

Guru Leon Cooperman ( Trades , Portfolio ) has been in the investment industry for nearly half a century. He started his career working at Goldman Sachs, but he retired 1991 and founded his own company Omega Advisors, which he runs today. Cooperman has been in the financial sector for close to half a century and most recently added 482,749 shares of Google ( NASDAQ:GOOGL ), a 125.94% increase to his holdings, and purchased 4,830,595 shares in Pfizer Inc. ( PFE ).

Google is also traded in Chile, Argentina and Germany.

1686185258.png

Google presently ranks No. 1 globally in search and popularity, according to Alexa.com. It also ranks No. 1 in the United States as the most used search engine. Google is a powerhouse with a market cap of $536.18 billion, a P/E ratio of 33.61, a P/S ratio of 7.58 and a PEG ratio of 2.23. Google is in a dominating position in search and has grown more than 30% since July 2015.

Charlie Munger (Trades, Portfolio) and Warren Buffett (Trades, Portfolio) of Berkshire Hathaway (NYSE:BRK.A) have investing rules, and one of their most important rules and investment philosophies is to ensure that a company has a moat surrounding to ensure that it can withstand fluctuation and variance of the market and stay in a dominating position long term. They recommend that, if you want to buy stocks and hold them forever, this is another reason why having a moat around your company is vital. According to Alexa, Google has almost four times as many searches per day as its next closest competition, Bing.

You can watch Buffett talk about companies having moats surrounding them on this YouTube video starting at 22:00.

Here below is a Peter Lynch chart of Google.

Qg_BUG_QkEgt3Dr33gtxWvWVOMnCWr4l28ziIgrW

Pfizer is also traded in the U.K., Belgium, Sweden, Switzerland, Chile, Mexico, Argentina and Brazil.

1484848615.png

Cooperman also made a large purchase of 4,830,595 shares in Pfizer. The company was incorporated in 1942 in Delaware. It is a research-based biopharmaceutical company that applies science and its resources to bring therapies to people that extend and improve their lives through the discovery, development and manufacture of health care products.

It has a market cap of $197.97 billion, a P/E ratio of 23.42, a P/S ratio of 4.13 and a dividend yield of 3.56.

MVVIZ3B6kJ3QtJn3e-XZ4LD8gsBxoEVqp4E63809

When it comes to investing, Cooperman has almost half a century of experience. It is not surprising that he took the low variance route by purchasing more shares in the search engine giant Google as well as acquiring a strong global pharmaceutical company that has been around for more than 50 years.

Cheers to your investment success.

About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GOOGL BRK.A PFE

Other Topics

Stocks